Alain Lamarre News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Hope for a cure for visceral leishmaniasis, an often fatal infectious disease

Hope for a cure for visceral leishmaniasis, an often fatal infectious disease
medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.

Alain lamarreLinh thuy maiArmand frappier santIrahl kingTania charpentierLiseth carmonaAlexandrep meliSharada swaminathanBiotechnologie research centreMcgill universityCell reportsFrappier santLiseth carmona p

Quebec Public Health Officials Recommend Province End Boosters For Those Under 60

Quebec public health officials are recommending to Premier François Legault's government that people under 60 years of age should .

Marnie cathcartAlain lamarreHealth ministryNational institute for scientific researchQuebec immunization committeePremier franNational instituteScientific researchCovid quebecCovid shotsCovid vaccineThe epoch times

New Sugar-Based Vaccine Being Developed for Melioidosis

The threat from Melioidosis is real. The bacterium that causes this infectious multisymptom illness is resistant to antibiotics, making diagnosis and

Charles gauthierBrad borleeAlain lamarreColorado state universityUniversity of oxfordUniversity college dublinCanadian institutes of health researchProfessor charles gauthierCanadian institutesHealth researchProfessor gauthierProfessor siobh

INRS professor developing a glycoconjugate vaccine for melioidosis

The threat from Melioidosis is real. The bacterium that causes this infectious multisymptom illness is resistant to antibiotics, making diagnosis and treatment more complex and resulting in a mortality rate of up to 50%.

Charles gauthierBrad borleeAlain lamarreEmily hendersonColorado state universityUniversity of oxfordUniversity college dublinCanadian institutes of health researchProfessor charles gauthierCanadian institutesHealth researchProfessor gauthierProfessor siobhImmune systemNeglected tropical diseasePreclinical testing

Étude menée au Québec | Une excellente efficacité vaccinale, selon l INSPQ

Les vaccins contre la COVID-19 ont une efficacité de plus de 97 % contre les décès et de 92 % contre les hospitalisations, même en présence du variant Delta, indique une nouvelle étude de l’Institut national de santé publique du Québec (INSPQ) publiée mercredi. Qui plus est, cette excellente efficacité vaccinale est aussi durable.

Alain lamarreNational healthLeague astrazenecaNational health of recallPhotograph olive treeArchives of the press aliceWith astrazenecaWith normandin